Important information
The information contained in this section of Biosergen’s website is restricted and is not for distribution, publication or dissemination, directly or indirectly, in or into the United States, Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Singapore, South Africa or any other jurisdiction where to do so may constitute a violation of applicable laws and regulations or require registration or other measures in addition to those required under Swedish law. You are requested to review the following information and make the following confirmation each time you seek to access this restricted section of Biosergen’s website. Your confirmation must be true and accurate.
Important information
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT WOULD BE UNLAWFUL.
Confirmation of Understanding
By proceeding to view the information and documents to which this gatepost gives access, you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by these terms and follow all restrictions, (3) are permitted under applicable law and regulation to proceed to the following parts of this website without the company being required to take further actions, (4) agree that you will not transmit or otherwise send any information contained in this part of the website to any person in the United States or to publications with a general circulation in the United States, and that you:
- are resident and physically present outside the United States, Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Singapore, South Africa or any other jurisdiction where the offer or sale of the Securities is not permitted
You don't have access to the page, go to the home page